This was confirmed in studies conducted in patients with breast cancer, which showed that increased S-nitrosylation leads to the activation of Ets-1 caused by MAPK-dependent phosphorylation and results in development of more aggressive breast cancer phenotype [41]. The gene discussed is ETS1; the disease is breast cancer.